Neurocrine Biosciences (NASDAQ:NBIX) reported its Q1 earnings results on Wednesday, May 3, 2023 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Neurocrine Biosciences missed estimated earnings by 492.31%, reporting an EPS of $-0.51 versus an estimate of $0.13.

Revenue was up $109.80 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.1 which was followed by a 1.14% drop in the share price the next day.

Here's a look at Neurocrine Biosciences's past performance:

To track all earnings releases for Neurocrine Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.